ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Dual energy x-ray absorptiometry (DEXA)"

  • Abstract Number: 1162 • ACR Convergence 2023

    Serial Imaging Changes in Skeletal Muscle Composition and Their Association with Clinical Outcomes in Idiopathic Inflammatory Myopathies

    Mamatha Gorijavolu1, Chengappa Kavadichanda1, Ramesh Ananthakrishnan1, Christina Mariaselvam1, Molly Thabah1 and VS Negi2, 1Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India, 2All India Institute of Medical Sciences, Bilaspur, Puducherry, India

    Background/Purpose: Muscle weakness in inflammatory myopathies (IIM) is due to muscle-edema, atrophy and fatty-infiltration among which edema is the predominant cause at baseline. Some IIM…
  • Abstract Number: 1996 • ACR Convergence 2023

    Variation in Dual-energy X-ray Absorptiometry Reporting: A National Survey of Veterans Health Administration Clinics

    Karla Miller1, Melissa Steffen2, Kimberly McCoy2, Michelle Mengeling2, Heather Davila2, Shylo Wardyn2 and Samantha Solimeo2, 1University of Utah School of Medicine, Salt Lake City, UT, 2Department of Veterans Affairs, Iowa City VA HCS, Iowa City, IA

    Background/Purpose: Dual-energy x-ray absorptiometry (DXA) is an important tool to identify Veterans with osteoporosis, assess fracture risk, and monitor treatment response. Variability in DXA acquisition,…
  • Abstract Number: 2001 • ACR Convergence 2023

    Burden of Metabolic Bone Disease in Patients with IgG4-Related Disease with and Without Autoimmune Pancreatitis

    Guy Katz1, Aubree McMahon1, Grace McMahon1, Isha Jha1, Marcy Bolster2, Ana Fernandes1, Zachary Wallace3, Cory Perugino1, John Stone4 and Yasmin Hernandez-Barco1, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Concord, MA, 3Massachusetts General Hospital, Newton, MA, 4Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Concord, MA

    Background/Purpose: Metabolic bone disease (MBD), including osteopenia and osteoporosis, is common in patients with inflammatory disorders, due to disease factors and glucocorticoid (GC) use, and…
  • Abstract Number: 2003 • ACR Convergence 2023

    Effects of Abaloparatide on Cortical and Trabecular Compartments by 3D-DXA in Men with Osteoporosis

    Ruban Dhaliwal1, John Boxberger2, Yamei Wang2, Bruce Mitlak2, Ludovic Humbert3 and Neil Binkley4, 1Massachusetts General Hospital, Boston, MA, 2Radius Health, Inc., Boston, MA, 33D-Shaper Medical, Barcelona, Spain, 4University of Wisconsin Osteoporosis Clinical Research Program, Madison, WI

    Background/Purpose: Abaloparatide (ABL) increases BMD in men with osteoporosis. In the Abaloparatide for the Treatment of Men with Osteoporosis (ATOM) trial, DXA-measured BMD change with…
  • Abstract Number: 2531 • ACR Convergence 2023

    Proton Pump Inhibitor Use Is Associated with Impaired Bone Mineral Density but Not Bone Microarchitecture in Patients with Inflammatory Rheumatic and Musculoskeletal Diseases Taking Glucocorticoids

    Andriko Palmowski1, Gabriela Schmajuk2, Jinoos Yazdany3, Patti Katz4, Jing Li5, Rachael Stovall5, Emma Kersey5, Sabrina Mai Nielsen6, Robin Christensen7, Henning Bliddal8, Zhivana Boyadzhieva9, Udo Schneider9, Tobias Alexander10, Burkhard Muche11, Sandra Hermann11, Edgar Wiebe11 and Frank Buttgereit11, 1Charité - Universitätsmedizin Berlin, Berlin, Germany, 2UCSF / SFVA, San Francisco, CA, 3University of California, General Department of Medicine, Division of Rheumatology, San Francisco, CA, 4University of California San Francisco, San Rafael, CA, 5University of California San Francisco, San Francisco, CA, 6The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark, 7Musculoskeletal Statistics Unit, The Parker Institute, Copenhagen, Denmark, 8The Parker Institute, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark, 9Charité Universitatsmedizine - Berlin, Berlin, Germany, 10Charité Universiätsmedizin Berlin, Dept. Rheumatology, Berlin, Germany, 11Charité Universitätsmedizin, Dept. Rheumatology, Berlin, Germany

    Background/Purpose: Patients with inflammatory rheumatic and musculoskeletal diseases (iRMDs) are at increased risk of osteoporosis and fragility fractures. For this population, whether proton pump inhibitor…
  • Abstract Number: 1098 • ACR Convergence 2023

    Improving Osteoporosis Screening in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis

    Kelly Tran1, Ellen Ann Sockman1, Rachel Salyer1, Megan Young1, Aisha Abbasi1 and Devanshu Verma2, 1West Virginia University Hospital, Morgantown, WV, 2West Virginia University, Morgantown, WV

    Background/Purpose: Osteoporosis is a medical condition associated with decreased bone mass and bone architecture, which increases incidence of fragility fractures(4). It is associated with 1.5…
  • Abstract Number: 0131 • ACR Convergence 2022

    Racial Differences in Bone Health of Sarcoidosis Patients: A Retrospective Study

    Emily Peninger1, Christian Ascoli2, Rachel Lane2, Subash Kukreja2, Robert Baughman3 and Nadera Sweiss2, 1University of Chicago, Chicago, IL, 2University of Illinois at Chicago, Chicago, IL, 3University of Cincinnati, Cincinnati, OH

    Background/Purpose: Bone health in sarcoidosis is a complex topic, though data regarding racial differences in this population is lacking. Our study sought to identify racial…
  • Abstract Number: 1276 • ACR Convergence 2022

    Bone Density Imaging: Evaluation of Equipment and Process of Care Quality in US Veterans

    Karla Miller1, Melissa Steffen2, Kimberly McCoy2, Michelle Mengeling2, Heather Davila2, Shylo Wardyn2 and Samantha Solimeo2, 1University of Utah Division of Rheumatology/VA Salt Lake City Health Care, Salt Lake City, UT, 2Iowa City VAMC, Iowa City, IA

    Background/Purpose: Osteoporotic fractures contribute to significant morbidity and mortality. Dual-energy x-ray absorptiometry (DXA) is a valuable tool to identify osteoporosis, assess fracture risk, and monitor…
  • Abstract Number: 1277 • ACR Convergence 2022

    Improving Patient Appropriate Osteoporosis Screening with Dual Energy X-ray Absorptiometry Scans in an Academic Internal Medicine Practice

    Nithin Pusapati1, Rebecca Fitzpatrick1, Manya Gupta1 and Sonali Khandelwal2, 1Rush University Medical Center, Chicago, IL, 2Rush University, Chicago, IL

    Background/Purpose: Nearly 53.6 million people in America have osteoporosis with increasing incidence each year (Brauer, JAMA 2009). Almost 25% of people with a hip fracture…
  • Abstract Number: 1305 • ACR Convergence 2022

    Characterizing Bone Microarchitecture with MRI in Patients with Systemic Lupus Erythematosus

    Joshua Novack1, Gregory Chang2, Stephen Honig1, Anmol Monga2, Xiaoliu Zhang3, Punam Saha3, Dimitri Martel2, Peter Izmirly4, H Michael Belmont5, Jill Buyon4 and Amit Saxena5, 1NYU Langone Health Department of Medicine, New York, NY, 2NYU Langone Health Department of Radiology, New York, NY, 3University of Iowa Departments of Radiology and Electrical and Computer Engineering, Iowa City, IA, 4NYU Grossman School of Medicine, New York, NY, 5NYU School of Medicine, New York, NY

    Background/Purpose: Fractures in patients with systemic lupus erythematosus (SLE) are more common than age and sex matched controls. Fracture risk is traditionally assessed by dual-energy…
  • Abstract Number: 1310 • ACR Convergence 2022

    Is the Trabecular Bone Score (TBS) a Useful Tool in Patients with Diffuse Idiopathic Skeletal Hyperostosis (DISH)?

    Bjoern Buehring1, David Kiefer2, Celina Mueller2, Roshnak Parvaee2, Marianti Ifanti2, Ioana Andreica3, Timm Westhoff4, Rainer Wirth4, Xenofon Baraliakos5, Nina Babel4 and Juergen Braun2, 1Bergisches Rheuma-Zentrum, Wuppertal, Germany, 2Rheumazentrum Ruhrgebiet, Herne, Germany, 3Rheumazentrum Ruhrgebiet, Ruhr-Universität-Bochum, Herne, Germany, 4Marienhospital Herne, Ruhr-University Bochum, Herne, Germany, 5Rheumazentrum Ruhrgebiet Herne, Herne, Germany

    Background/Purpose: Patients with rheumatic and musculoskeletal diseases (RMD) have an increased fracture risk (FxR). Diffuse idiopathic skeletal hyperostosis (DISH) is a non-inflammatory disease characterized by…
  • Abstract Number: 1317 • ACR Convergence 2022

    The Epidemiology of Old versus Young Males Referred for BMD Assessment

    Muhammed Aqib Khan1, Rabie Hamad1, Hamzah Amin1 and Marwan Bukhari2, 1Royal Lancaster Infirmary, Lancaster, United Kingdom, 2University Hospitals of Morecambe Bay NHS Trust, Lancaster, United Kingdom

    Background/Purpose: Data on osteoporosis in men are scarce. The World Health Organisation's (WHO) definition of a T-score less than 2.5 has only been described for…
  • Abstract Number: 1319 • ACR Convergence 2022

    Prognostic Utility of Metacarpal Bone Mineral Density Measurement in Patients with Recent-onset Arthritis by Assessment of Radiographic Progression at 2-year Follow Up

    Irene Maria Llorente Cubas1, Ana Maria Fernandez Ortiz2, Jesus Alberto Garcia Vadillo1, Jose ivorra Cortes3, Luis Rodriguez-Rodriguez4, Rosario Garcia-Vicuña5, Santos Castañeda6, Isidoro Gonzalez1 and Ana M Ortiz1, 1Hospital Universitario de La Princesa, Madrid, Spain, 2Hospital Universitario de Badajoz, Badajoz, Spain, 3Hospital Universitario de La Fe, València, Spain, 4Instituto de Investigación Sanitaria San Carlos, Rheumatology, Madrid, Spain, 5Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain, 6Division of Rheumatology, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain

    Background/Purpose: Rheumatoid arthritis (RA) and osteoporosis (OP) have a complex interplay in terms of pathogenic mechanisms. In this regard, radiogrammetry (DXR) of the hand, a…
  • Abstract Number: 1320 • ACR Convergence 2022

    Performance of FRAX® Brazil and NOGG Methodology with and Without Bone Mineral Density upon Predicting Fractures on a Community-Dwelling Elderly Population with High Incidence of Osteoporotic Fractures: The São Paulo Ageing and Health (SPAH) Study

    Thiago Q Freitas1, Leonardo F G Olalla1, Liliam Takayama1, Valeria Caparbo2, camille figueiredo2, Luana Machado3, Diogo Domiciano4 and Rosa Pereira2, 1University of São Paulo, São Paulo, Brazil, 2Bone Metabolism Laboratory, Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 3Hospital das Clinicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 4Hospital das Clinicas, Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: SPAH is a prospective cohort of ≥65-year-old community-dwelling elderly with high fracture risk (40.3/1,000 person-years in women and 30.6/1,000 in men for vertebral fractures…
  • Abstract Number: 1325 • ACR Convergence 2022

    The Risks of Osteoporotic Fracture After Lung Transplant: A Retrospective Cohort Study at an International Transplant Center

    Adil Vural1, Sarah Keller2, Neel Tapryal3, Komal Mushtaq4, Hassan Shaheen1, Chao Zhang2, Marie Budev2, Abby Abelson2 and Chad Deal5, 1Cleveland Clinic, Westlake, OH, 2Cleveland Clinic, Cleveland, OH, 3Cleveland Clinic, Rocky River, OH, 4Cleveland Clinic, Fairview Park, OH, 5Cleveland Clinic, Shaker Heights, OH

    Background/Purpose: Osteoporotic fractures are a well-known complication of lung transplant (LT) and can significantly impact the quality of life of LT recipients. Although much is…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology